Skip to main content

Search Tufts Medicine

Search Filters

Type
medical-person
Need care for your condition?
Displaying 1 - 20 of 209
page
...
Tufts Medicine doctors can help you stay safe from COVID-19, and they're also here to diagnose and treat it if you need it.
page
...
During the COVID-19 pandemic, starting in March 2020, we persisted and completed many personal and professional tasks.
Accomplishments During COVID-19
page
...
The COVID-19 biorepository and comprehensive database have been created to accelerate a wide variety of research efforts including characterizing the basic pathophysiology of the disease, its clinical outcomes as well as the development of diagnostic tests, vaccines and treatments.
clinical trial
...

The study is seeking to create a repository of blood samples from participants who have a history of testing positive for COVID-19 to help accelerate current and future COVID-19 research.

Articles
February 16, 2021
We spoke with Amanda Vest, MD from the CardioVascular Center at Tufts Medical Center about what doctors have learned so far about the connection between COVID-19 and pre-existing heart conditions.
Articles
February 14, 2021
Learn the differences between coronavirus, COVID-19 and the flu.
clinical trial
...

This patient registry aims to recruit people who have recovered following infection with SARS-CoV-2 / COVID-19 for the purpose of connecting them with researchers in the United States who are conducting research to learn about the survivor experience, and develop new treatments for patients currently with the illness.

Patient Stories
November 4, 2021
When Frank Basler, 58, and his son were in Killington, VT at a bachelor party in March 2020 their only concern was having a good time. The expectant grandfather was enjoying spending time with his son and their friends in the mountains of Vermont. Nine days later, Frank was on a ventilator fighting to breathe.

Italian Covid-19 Vaccination Literacy Scale

Covid-19-VLS-It Italian Covid-19 Vaccination Literacy Scale LR Biasio

Biasio, L. R., Bonaccorsi, G., Lorini, C., & Pecorelli, S. (2021). Assessing COVID-19 vaccine literacy: a preliminary online survey. Human vaccines & immunotherapeutics, 17(5), 1304–1312. https://doi.org/10.1080/21645515.2020.1829315

2020

Covid-19 Vaccine Literacy Scale (VLS) has been developed to assess vaccine literacy in adults about Covid-19 vaccination. The scale was derived from the tool HLVa-IT (Health Literacy about Vaccination of adults in ITalian - HLVa-IT)

1 12 1

HLVa-IT Cocid-19-VLS is composed of 12 items (questions) divided into two scales, functional (items 1 to 4) and interactive-critical (items 5 to 12).
From the psychometric point of view, functional VL questions are more about language capabilities, involving the semantic system, while the interactive-critical questions regard more the cognitive efforts, such as problem solving and decision making.
The answers are supplied by the interviewee according to a four-point Likert scale

0 minutes 885 5 minutes

The tool was developed based on HLVa-IT (Health Literacy about Vaccination of adults in ITalian)
Some questions were adapted to the vaccination domain and cultural characteristics of the Italian population.

Answers to functional and interactive-critical questions showed good/acceptable internal consistency (Cronbach’s alpha = 0.8500 and 0.7672, respectively)

lrbiasio@gmail.com https://www.tandfonline.com/doi/full/10.1080/21645515.2020.1829315 https://www.tandfonline.com/doi/full/10.1080/21645515.2020.1829315 lrbiasio@gmail.com /sites/default/files/webform/suggest-measure/1006/covid-19-vls-it.pdf Prose: Comprehension, Information seeking: Document Italy Computer-based Vaccination, Infectious Disease, Health Promotion Older Adults: 65+ years, Adults: 18 to 64 years English Self-reported 0.850
Service
In our increasingly connected world, many of us travel to and from developing countries every year. If you’re traveling to another country, our team of travel medicine experts will work with you to prepare and protect you from potential travel-related health risks. ...
Announcements
July 24, 2021
Our number one priority is the health and safety of our patients, employees and clinicians. That is why today we are announcing that we will require those who work within our hospitals and health system to be vaccinated against COVID-19 following the full FDA approval of one of the current vaccines. We anticipate this happening later this year.
In the News
September 24, 2024
Shira Doron, MD, Chief Infection Control Officer for Tufts Medicine and Hospital Epidemiologist at Tufts Medical Center, in a story about important things to know about flu and COVID-19 vaccines, as respiratory virus season approaches.
Articles
October 2, 2021
Your initial vaccination offers strong protection against the COVID-19 virus, and are working well to prevent severe illness, hospitalization and death, even against the widely circulating Delta variant. However, public health experts are starting to see reduced protection, especially among certain populations, against mild and moderate disease.
Jump back to top